Always Caring. Always Here.


Seaford, Delaware: Nanticoke Health Services is excited to offer the latest in breast cancer screening advances, Genius™ 3D MAMMOGRAPHY™ exams, developed  by Hologic, Inc. Hologic is a worldwide leader in Women’s Health.[i] Utilizing advanced breast tomosynthesis technology, Genius exams are clinically proven to significantly increase the detection of breast cancers, while simultaneously decreasing the number of women asked to return for additional testing.

In conventional 2D mammography, overlapping tissue is a leading reason why small breast cancers may be missed and normal tissue may appear abnormal, leading to unnecessary callbacks. A 3D mammogram at Nanticoke includes a three-dimensional method of imaging that can greatly reduce the tissue overlap effect.

This exam includes both 2D images and tomosynthesis scans. During the tomosynthesis-DIMENSIONAL portion of the exam, an X-ray arm sweeps in a slight arc over the breast, taking multiple images. A computer then converts the images into a stack of thin layers, allowing the radiologist to review the breast tissue one layer at a time. A 3D exam takes just a few seconds longer than a conventional 2D breast cancer screening exam.

The Hologic system is the only clinically superior breast tomosynthesis system as approved by the FDA. The new system is recommended for women of all ages and breast densities. The system allows our radiologists to more effectively pinpoint the size, shape and location of abnormalities. This leads to better detection and greater peace of mind for our patients.

The largest study to date on breast cancer screening using the Genius exam was published in the June 25, 2014 issue of the Journal of the American Medical Association (JAMA).[ii]  Findings include:

  • A 41% increase in the detection of invasive breast cancers.
  • A 29% increase in the detection of all breast cancers.
  • A 15% decrease in women recalled for additional imaging.

Nanticoke Health Services is committed to the fight against breast cancer. In offering the Genius exam, Nanticoke provides the latest and most effective imaging tool for breast cancer screening.

“We are extremely pleased to be able to offer 3D mammography at Nanticoke,” said Missy Babinski, Director of Radiology at Nanticoke Health Services. “This latest technology allows for better, earlier breast cancer detection. The Genius™ 3D MAMMOGRAPHY™ equipment allows the radiologist to better evaluate your breast tissue layer by layer. The ultimate goal is to screen for breast cancer with greater accuracy.”

If you would like to schedule a 3D mammogram at Nanticoke, please call 302-628-1507. For more information about this important breast health procedure, please contact our Mammography department at 302-629-6611 x 8630 or visit

Virtual Tour:

About Genius™ 3D MAMMOGRAPHY™ Exams

The breast is a three-dimensional object composed of different structures located at different heights within the breast. These structures can overlap and cause confusion when viewed as a flat two-dimensional image. This confusion of overlapping of tissue is a leading reason why small breast cancers may be missed and normal tissue may appear abnormal, leading to unnecessary callbacks. Using breast tomosynthesis technology, the Hologic system creates a 3-dimensional image of the breast structure, which enables radiologists to more clearly see through overlapping tissue to detect cancers, often at an earlier stage.

The Hologic system is the first FDA-approved breast tomosynthesis system in the U.S. Hologic Genius 3D MAMMOGRAPHY™ exams are now available in all 50 states and over 50 countries. To date, more than 8 million women have been screened with this advanced screening system.

[i] Genius™ 3D Mammography™ exams are available only on the Hologic Selenia® Dimensions® system.

[ii] Friedewald SM, Rafferty EA, Rose SL, Durand MA, Plecha DM, Greenberg JS, Hayes MK, Copit DS, Carlson KL, Cink TM, Barke LD, Greer LN, Miller DP, Conant EF, Breast Cancer Screening Using Tomosynthesis in Combination with Digital Mammography, JAMA June 25, 2014.

Comments are closed.